市場調査レポート

商品コード

1403436

経皮吸収型皮膚パッチ市場の2030年までの予測：成分別、用途別、流通チャネル別、地域別の世界分析

Transdermal Skin Patches Market Forecasts to 2030 - Global Analysis By Component, By Application, Distribution Channel and By Geography

出版日: 2024年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 609,303円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 770,805円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 932,307円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,101,150円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、経皮吸収型皮膚パッチの世界市場は2023年に82億米ドルを占め、予測期間中にCAGR 6.6％で成長し、2030年には128億米ドルに達する見込みです。

経皮吸収型皮膚パッチは、皮膚から血流に薬剤を送達するように設計された医療機器です。粘着剤、薬物リザーバー、制御膜などの層で構成されるこのパッチは、制御された継続的な薬物放出を提供します。パッチは皮膚に接着し、消化器系をバイパスして薬物が循環系に直接吸収されるようにします。様々な薬物のための便利で非侵襲的な送達方法を提供し、長期にわたって安定した治療レベルを維持します。

GLOBOCAN 2020報告書によると、2020年にはメキシコで195,499人のがん患者が報告され、人口の中で最も多いのは乳がんと前立腺がんです。

成長促進要因：経口薬や服用薬に比べて利点が増加

経皮パッチへの嗜好が高まっているのは、経口薬とは異なる利点があるからです。これらのパッチは非侵襲的なドラッグデリバリーを提供し、消化器系をバイパスして胃腸の副作用を軽減します。薬物の安定した制御放出を保証し、一貫した治療レベルを維持し、患者のコンプライアンスを向上させる。投与回数が少なく、貼付が簡便であるため、特に長期の治療において利便性が高いです。さらに、経皮パッチは消化管での薬物分解に関する問題を緩和し、バイオアベイラビリティを向上させ、従来の経口薬に代わる有望な選択肢を提供します。

成長抑制要因：認知度の低さと製品コストの上昇

経皮吸収型皮膚パッチを取り巻く認知度の低さと製品コストの高さが大きな障害となっています。消費者やヘルスケア専門家の間で、経皮パッチの利点や用途に関する知識が不十分であることが、その採用を制限する可能性があります。さらに、パッチの処方や製造にかかる製造コストの高騰が市場価格の上昇につながり、一部の患者の利用しやすさに影響を与えています。このような複合的な要因が、広く受け入れられ手頃な価格で入手する妨げとなり、この効果的なドラッグデリバリーシステムが様々な病状に利用される可能性を妨げています。

機会：処方用経皮パッチのニーズの高まり

処方用経皮パッチに対する需要の高まりは、経皮吸収型皮膚パッチ市場に大きな機会をもたらしています。この急増は、経口以外の薬物送達方法に対する嗜好の進化と患者の利便性重視の高まりを反映しています。個別化医療や標的療法へのシフトに伴い、処方箋に基づく特殊なパッチのニーズが高まっています。また、パッチ技術の向上に関する調査も促進され、治療の選択肢が拡大し、経皮投薬分野の市場成長を牽引しています。

脅威：皮膚の様々な活性物質吸収能力の限界

皮膚の選択的透過性は経皮吸収パッチにとって課題となります。この制限により、経皮投与に適した薬剤の範囲が制限され、特定の治療法の開発が妨げられます。さらに、高分子、親水性化合物、特定の化学的性質を持つ化合物は、皮膚バリアを効果的に通過することが難しく、経皮投与に適した物質の範囲が制限されます。

COVID-19の影響

COVID-19の流行は経皮吸収型皮膚パッチ市場に大きな影響を与えました。鎮痛剤やホルモン療法など、特定のパッチに対する需要は堅調に推移したが、サプライチェーンやヘルスケアへのアクセスの混乱は生産と流通に影響を与えました。ロックダウンは患者の診察にも影響を与え、パッチ使用者の新規処方や定期検診を妨げる可能性があった。しかし、パンデミックは非侵襲的ドラッグデリバリー法の重要性を浮き彫りにし、将来的には経皮パッチのさらなる革新と普及を促進する可能性があります。

予測期間中、粘着剤入り薬剤セグメントが最大になる見込み

接着剤入り薬剤セグメントは、その優位性から予測期間中に市場を独占すると予想されます。粘着剤入り薬剤パッチは、薬物を粘着剤層に直接組み込むことで、正確な投与と皮膚接触の向上を保証します。このデザインは、利便性、適用の簡便性、安定したドラッグデリバリーを提供します。さらに、偶発的な剥離のリスクも最小限に抑えることができます。ユーザーフレンドリーなアプリケーションと信頼性の高い薬物放出プロファイルにより、薬物粘着パッチは今後も好まれる選択肢であり続けると予想され、市場での存在感を高めています。

病院薬局セグメントは予測期間中に最も高いCAGRが見込まれる

病院薬局セグメントは、さまざまな要因によって大きな成長が見込まれています。病院は患者のケアにおいて極めて重要な役割を果たしており、経皮吸収パッチを含む医薬品の主要な流通拠点となっています。長期投薬が必要な慢性疾患の有病率の増加と経皮ドラッグデリバリーシステムの採用率の上昇が、病院薬局の需要を促進しています。さらに、病院内でのパッチの入手と投与の利便性が、市場の大幅な成長予測に寄与しています。

最大シェアの地域

北米は、高度なヘルスケアインフラ、高い医療費、ドラッグデリバリーシステムの技術的進歩への強い関心から、経皮吸収型皮膚パッチ市場をリードすると予想されます。さらに、慢性疾患を抱える高齢者人口の増加と生活習慣病の流行が経皮パッチの需要を促進しています。さらに、支持的な規制の枠組みや主要な市場プレイヤーの強力なプレゼンスが、北米の優位性に寄与しています。

CAGRが最も高い地域

アジア太平洋地域は、人口の拡大、ヘルスケア意識の高まり、慢性疾患の有病率の増加により、経皮吸収型テープ製剤市場の顕著な成長が見込まれています。さらに、ヘルスケアインフラの改善、非侵襲的治療へのシフト、ヘルスケアの進歩を促進する新興国の存在が、アジア太平洋地域の大幅な成長予測に寄与しています。さらに、政府の積極的な取り組みや、ヘルスケアへのアクセスの向上に重点を置いていることも、この地域の市場拡大を後押ししています。

無料カスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

企業プロファイル
- 追加市場企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第9章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第10章企業プロファイル

4P Therapeutics
AdhexPharma
Aveva Drug Delivery Systems
Bayer AG
Corium, LLC
GlaxoSmithKline（GSK）
Hisamitsu Pharmaceutical Co., Inc.
Johnson & Johnson
Luye Pharma Group
Mundipharma
Mylan N.V.
Nitto Denko Corporation
Novartis
Pfizer Inc.
Praj HiPurity Systems Limited
ProSolus Pharmaceuticals
Sorrento Therapeutics Inc
Teva Pharmaceuticals
TheraDep Technologies
Transdermal Delivery Solutions Corporation

図表

List of Tables

Table 1 Global Transdermal Skin Patches Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
Table 3 Global Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
Table 4 Global Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
Table 5 Global Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
Table 6 Global Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
Table 7 Global Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
Table 8 Global Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
Table 9 Global Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
Table 10 Global Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
Table 11 Global Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
Table 12 Global Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
Table 13 Global Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
Table 14 Global Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
Table 15 Global Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 16 Global Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
Table 17 Global Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
Table 18 Global Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
Table 19 Global Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 20 Global Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 21 Global Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 22 Global Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 23 North America Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
Table 24 North America Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
Table 25 North America Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
Table 26 North America Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
Table 27 North America Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
Table 28 North America Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
Table 29 North America Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
Table 30 North America Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
Table 31 North America Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
Table 32 North America Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
Table 33 North America Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
Table 34 North America Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
Table 35 North America Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
Table 36 North America Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
Table 37 North America Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 38 North America Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
Table 39 North America Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
Table 40 North America Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
Table 41 North America Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 42 North America Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 43 North America Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 44 North America Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 45 Europe Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
Table 46 Europe Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
Table 47 Europe Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
Table 48 Europe Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
Table 49 Europe Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
Table 50 Europe Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
Table 51 Europe Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
Table 52 Europe Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
Table 53 Europe Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
Table 54 Europe Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
Table 55 Europe Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
Table 56 Europe Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
Table 57 Europe Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
Table 58 Europe Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
Table 59 Europe Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 60 Europe Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
Table 61 Europe Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
Table 62 Europe Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
Table 63 Europe Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 64 Europe Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 65 Europe Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 66 Europe Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 67 Asia Pacific Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
Table 68 Asia Pacific Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
Table 69 Asia Pacific Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
Table 70 Asia Pacific Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
Table 71 Asia Pacific Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
Table 72 Asia Pacific Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
Table 73 Asia Pacific Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
Table 74 Asia Pacific Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
Table 75 Asia Pacific Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
Table 76 Asia Pacific Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
Table 77 Asia Pacific Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
Table 78 Asia Pacific Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
Table 79 Asia Pacific Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
Table 80 Asia Pacific Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
Table 81 Asia Pacific Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 82 Asia Pacific Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
Table 83 Asia Pacific Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
Table 84 Asia Pacific Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
Table 85 Asia Pacific Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 86 Asia Pacific Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 87 Asia Pacific Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 88 Asia Pacific Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 89 South America Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
Table 90 South America Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
Table 91 South America Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
Table 92 South America Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
Table 93 South America Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
Table 94 South America Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
Table 95 South America Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
Table 96 South America Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
Table 97 South America Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
Table 98 South America Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
Table 99 South America Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
Table 100 South America Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
Table 101 South America Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
Table 102 South America Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
Table 103 South America Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 104 South America Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
Table 105 South America Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
Table 106 South America Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
Table 107 South America Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 108 South America Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 109 South America Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 110 South America Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 111 Middle East & Africa Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
Table 112 Middle East & Africa Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
Table 113 Middle East & Africa Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
Table 114 Middle East & Africa Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
Table 115 Middle East & Africa Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
Table 116 Middle East & Africa Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
Table 117 Middle East & Africa Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
Table 118 Middle East & Africa Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
Table 119 Middle East & Africa Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
Table 120 Middle East & Africa Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
Table 121 Middle East & Africa Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
Table 122 Middle East & Africa Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
Table 123 Middle East & Africa Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
Table 124 Middle East & Africa Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
Table 125 Middle East & Africa Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
Table 126 Middle East & Africa Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
Table 127 Middle East & Africa Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
Table 128 Middle East & Africa Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
Table 129 Middle East & Africa Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 130 Middle East & Africa Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 131 Middle East & Africa Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 132 Middle East & Africa Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)

Product Code: SMRC24661

According to Stratistics MRC, the Global Transdermal Skin Patches Market is accounted for $8.2 billion in 2023 and is expected to reach $12.8 billion by 2030 growing at a CAGR of 6.6% during the forecast period. Transdermal skin patches are medical devices designed to deliver medication through the skin and into the bloodstream. Comprising layers including an adhesive, drug reservoir and a controlling membrane, these patches offer controlled, continuous drug release. They adhere to the skin, allowing drugs to be absorbed directly into circulation, bypassing the digestive system. They provide a convenient, non-invasive delivery method for various medications, maintaining steady therapeutic levels over time.

According to the GLOBOCAN 2020 report, 195,499 cancer cases were reported in Mexico in 2020, with breast and prostate cancers being the most common among the population.

Market Dynamics:

Driver:

Increasing advantages over the oral and ingesting medications

The rising preference for transdermal skin patches is fueled by their distinct advantages over oral medication. These patches offer non-invasive drug delivery, bypassing the digestive system and reducing gastrointestinal side effects. They ensure a steady, controlled release of medication, maintain consistent therapeutic levels and enhance patient compliance. With fewer dosing frequencies and simplified application, they provide convenience, especially for long-term therapies. Additionally, transdermal patches mitigate issues related to drug degradation in the digestive tract, improving bioavailability and offering a promising alternative to traditional oral medications.

Restraint:

Lack of awareness and elevated product costs

The limited awareness surrounding transdermal skin patches and their higher product costs pose significant restraints. Insufficient knowledge among consumers and healthcare professionals about their benefits and applications may limit their adoption. Moreover, elevated production expenses involved in formulating and manufacturing these patches contribute to higher market prices, impacting accessibility for some patients. These combined factors hinder widespread acceptance and affordability, impeding the potential utilization of this effective drug delivery system for various medical conditions.

Opportunity:

Growing need for prescription transdermal patches

The increasing demand for prescription transdermal patches presents a significant opportunity in the transdermal skin patch market. This surge reflects evolving preferences for non-oral drug delivery methods and a growing emphasis on patient convenience. With a shift toward personalized medicine and targeted therapies, the need for specialized, prescription-based patches is rising. It also fuels research into enhanced patch technologies, expanding treatment options and driving market growth in the transdermal medication sector.

Threat:

Skin's limited capacity to absorb various active substances

The skin's selective permeability poses a challenge for transdermal patches, as not all substances can effectively penetrate its barriers. This limitation restricts the range of medications suitable for transdermal delivery, hindering the development of certain therapies. Additionally, large molecules, hydrophilic compounds and those with specific chemical properties struggle to traverse the skin barrier effectively, limiting the range of substances suitable for transdermal delivery.

COVID-19 Impact:

The COVID-19 pandemic has significantly influenced the transdermal skin patches market. While demand for certain patches, like those delivering pain relief or hormone therapies, remained steady, disruptions in supply chains and healthcare access impacted production and distribution. Lockdowns also affected patient consultations, potentially hindering new prescriptions and routine check-ups for patch users. However, the pandemic underscored the significance of non-invasive drug delivery methods, potentially driving further innovation and adoption of transdermal patches in the future.

The drug-in-adhesive segment is expected to be the largest during the forecast period

The drug-in-adhesive segment is expected to dominate the market during the forecast period due to its advantages. Drug-in-adhesive patches integrate the drug directly into the adhesive layer, ensuring precise dosing and enhanced skin contact. This design offers convenience, simplicity in application, and consistent drug delivery. Moreover, it minimizes the risk of accidental detachment. With its user-friendly application and reliable drug release profile, the drug-in-adhesive patch is anticipated to remain the preferred choice, fostering its prominence in the market.

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period

The hospital pharmacies segment is poised for significant growth due to various factors. Hospitals play a pivotal role in patient care and are key distribution points for pharmaceuticals, including transdermal patches. The increasing prevalence of chronic diseases requiring long-term medication, coupled with the rising adoption of transdermal drug delivery systems, is driving demand in hospital pharmacies. Additionally, the convenience of obtaining and administering patches within a hospital setting contributes to the projected substantial growth of the market.

Region with largest share:

North America is anticipated to lead the transdermal skin patches market due to its advanced healthcare infrastructure, high healthcare expenditure and robust focus on technological advancements in drug delivery systems. Additionally, a growing elderly population with chronic conditions, coupled with the prevalence of lifestyle-related diseases, fuels the demand for transdermal patches. Moreover, supportive regulatory frameworks and a strong presence of key market players contribute to North America's anticipated dominance.

Region with highest CAGR:

Asia Pacific is poised for notable growth in the transdermal skin patches market owing to the region's expanding population, rising healthcare awareness and increasing prevalence of chronic diseases. Moreover, improving healthcare infrastructure, a shift towards non-invasive treatments, and the presence of emerging economies fostering healthcare advancements contribute to the projected substantial growth in Asia Pacific. Additionally, supportive government initiatives and a focus on enhancing healthcare accessibility further propel market expansion in this region.

Key players in the market:

Some of the key players in transdermal skin patches market include 4P Therapeutics, AdhexPharma, Aveva Drug Delivery Systems, Bayer AG, Corium, LLC, GlaxoSmithKline (GSK), Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Luye Pharma Group, Mundipharma, Mylan N.V., Nitto Denko Corporation, Novartis, Pfizer Inc., Praj HiPurity Systems Limited, ProSolus Pharmaceuticals, Sorrento Therapeutics Inc, Teva Pharmaceuticals, TheraDep Technologies and Transdermal Delivery Solutions Corporation.

Key Developments:

In April 2023, researchers at MIT University developed a wearable patch that enables painless skin patch delivery. The patch utilizes painless ultrasonic waves to create tiny channels, allowing drugs to pass through the tough outer layer of the skin. This innovative approach holds the potential for delivering treatments for various skin conditions. This patch can also be adapted for delivering muscle relaxants, hormones, and other drugs.

In September 2022, Corium launched its Adlarity (donepezil transdermal system) for prescription use in the US Adlarity, a once-weekly patch, delivers consistent doses of donepezil through the skin. It could treat patients with mild, moderate, or severe dementia of Alzheimer's type.

In April 2022, Luye Pharma Group announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) had accepted the Marketing Authorization Application (MAA) for the company's investigational Rivastigmine Twice Weekly Transdermal Patch that was indicated for treating Alzheimer's disease of mild to moderate symptoms.

Components Covered:

Reservoir
Drug-in-Adhesive
Matrix
Microneedle
Other Components

Applications Covered:

Pain Management
Cardiovascular Disorders
Central Nervous System Disorders
Hormonal Therapy
Neurological Disorders
Nicotine Cessation
Overactive Bladder
Other Applications

Distribution Channels Covered:

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Transdermal Skin Patches Market, By Component

5.1 Introduction
5.2 Reservoir
5.3 Drug-in-Adhesive
- 5.3.1 Single Layer
- 5.3.2 Multilayer
5.4 Matrix
5.5 Microneedle
5.6 Other Components

6 Global Transdermal Skin Patches Market, By Application

6.1 Introduction
6.2 Pain Management
6.3 Cardiovascular Disorders
6.4 Central Nervous System Disorders
6.5 Hormonal Therapy
6.6 Neurological Disorders
6.7 Nicotine Cessation
6.8 Overactive Bladder
6.9 Other Applications

7 Global Transdermal Skin Patches Market, By Distribution Channel

7.1 Introduction
7.2 Hospital Pharmacies
7.3 Online Pharmacies
7.4 Retail Pharmacies

8 Global Transdermal Skin Patches Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 4P Therapeutics
10.2 AdhexPharma
10.3 Aveva Drug Delivery Systems
10.4 Bayer AG
10.5 Corium, LLC
10.6 GlaxoSmithKline (GSK)
10.7 Hisamitsu Pharmaceutical Co., Inc.
10.8 Johnson & Johnson
10.9 Luye Pharma Group
10.10 Mundipharma
10.11 Mylan N.V.
10.12 Nitto Denko Corporation
10.13 Novartis
10.14 Pfizer Inc.
10.15 Praj HiPurity Systems Limited
10.16 ProSolus Pharmaceuticals
10.17 Sorrento Therapeutics Inc
10.18 Teva Pharmaceuticals
10.19 TheraDep Technologies
10.20 Transdermal Delivery Solutions Corporation